NCT02053779View on ClinicalTrials.gov

GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT

PHASE3CompletedINTERVENTIONAL

Enrollment

328

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Infertility

Interventions

DRUG

Triptorelin 0.1mg

Triptorelin 0.1 mg administered subcutaneously 6 days after ovum pick-up (OPU) in IVF/ICSI cycles triggered by triptorelin 0.2 mg followed by hCG 1500 iu the day of OPU.

Trial Locations (1)

25000

Ibn Rochd Infertility Centre, Constantine

All Listed Sponsors

lead

Centre Hospitalier Universitaire Ibn Rochd

OTHER

NCT02053779 - GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT | Biotech Hunter | Biotech Hunter